Senior Director, New Product Planning

Mirum Pharmaceuticals•Foster City, CA

6d•Hybrid

About The Position

Mirum Pharmaceuticals is a biopharmaceutical company focused on transforming the treatment of rare diseases. Reporting to the SVP of Corporate Development and Strategy, the Senior Director, New Product Planning will help shape the company’s future portfolio by leading commercial strategy for pipeline assets, identifying lifecycle opportunities, evaluating external innovation, and defining areas for growth. The role serves as commercial strategy lead for pre-Phase 3 programs and works across Research, Clinical Development, Medical Affairs, US and International Commercial, Business Development, Corporate Strategy, and Finance to integrate scientific, clinical, commercial, and financial perspectives into development and investment decisions. The position connects science with strategy to identify indications, evaluate portfolio opportunities, and shape clinical development and investment decisions based on unmet need, the competitive landscape, and strategic value drivers. The ideal candidate brings scientific depth, commercial judgment, and strategic and financial acumen.

Requirements

10+ years of experience in the biotechnology or pharmaceutical industry, including significant experience in New Product Planning, Commercial Strategy, Portfolio Strategy, Business Development, Business Analytics, Marketing, Market Access, or related roles.
Strong scientific acumen and ability to understand disease biology, molecular pathways, mechanisms of action, and clinical data and translate them into commercial and development strategy.
Experience shaping strategy for pipeline assets, preferably during early- and mid-stage clinical development.
Experience evaluating new indications, lifecycle opportunities, new therapeutic areas, and/or external innovation opportunities.
Strong experience with commercial forecasting, primary and secondary market research, business cases, and asset valuation.
Demonstrated ability to influence senior leaders and cross-functional teams without direct authority.
Ability to communicate complex scientific, clinical, and commercial concepts effectively to scientific experts and senior executives.

Nice To Haves

PhD or MD; other advanced scientific or medical degrees with relevant experience will be considered.
Experience in rare disease and/or specialty therapeutics.
Experience collaborating with global commercial teams and working across multiple therapeutic areas.
Experience supporting licensing, acquisition, or other business development transactions.
Experience presenting strategic recommendations to Executive Leadership and governance committees.

Responsibilities

Lead commercial assessments of licensing, acquisition, and partnership opportunities, integrating scientific rationale, unmet need, clinical profile, competitive landscape, commercial potential, pricing and market access, and strategic fit.
Conduct primary and secondary market research to develop patient-based forecasts, scenario analyses, and risk-adjusted valuations for investment and transaction decisions.
Partner with Business Development, R&D, Finance, and US and Global Commercial teams throughout opportunity evaluation and diligence.
Serve as commercial strategy lead on cross-functional product teams for pre-Phase 3 pipeline programs before transition.
Develop business cases and commercial strategies for pipeline assets, including indication prioritization, Target Product Profiles, patient segmentation, value story, competitive differentiation, market opportunity, and lifecycle planning.
Partner with Research, Clinical Development, Market Access, and Medical Affairs to integrate commercial considerations into development strategy, including patient populations, endpoints, comparators, and real-world and health economic evidence generation.
Partner with US and Global Commercial leaders to incorporate key-market perspectives and support transition of assets into late-stage commercial planning.
Evaluate new therapeutic areas and disease spaces by integrating disease biology, unmet need, competitive dynamics, development feasibility, and commercial potential.
Shape portfolio and corporate strategy by identifying growth opportunities, strategic gaps, and investment and resource-allocation priorities.
Own commercial assumptions that inform long-range planning for all pre-Phase 3 programs.
Monitor scientific, clinical, competitive, regulatory, and market developments and translate them into implications for product and portfolio strategy.